Faculty Opinions recommendation of Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study.

2011 ◽  
Author(s):  
Henry Kaplan ◽  
Sarah Haji Abdollahi
Keyword(s):  
Pilot Study ◽  
Pars Plana Vitrectomy ◽  
Immunomodulatory Therapy ◽  
Intermediate Uveitis ◽  
Pars Plana

Pars Plana Vitrectomy versus Immunomodulatory Therapy for Intermediate Uveitis: A Prospective, Randomized Pilot Study

2010 ◽  
Vol 18 (5) ◽  
pp. 411-417 ◽  
Author(s):  
Karina Quinones ◽  
John Y. Choi ◽  
Taygan Yilmaz ◽  
Chrysanthi Kafkala ◽  
Erik Letko ◽  
...  
Keyword(s):  
Pilot Study ◽  
Pars Plana Vitrectomy ◽  
Immunomodulatory Therapy ◽  
Intermediate Uveitis ◽  
Pars Plana

Pars plana vitrectomy in patients with intermediate uveitis

2001 ◽  
Vol 9 (3) ◽  
pp. 141-151 ◽  
Author(s):  
Panagiota Stavrou ◽  
Stefanos Baltatzis ◽  
Erik Letko ◽  
C. Michael Samson ◽  
William Christen ◽  
...  
Keyword(s):  
Pars Plana Vitrectomy ◽  
Intermediate Uveitis ◽  
Pars Plana

Intraocular Nanoparticle Drug Delivery: A Pilot Study Using an Aerosol during Pars Plana Vitrectomy

2007 ◽  
Vol 48 (11) ◽  
pp. 5243 ◽  
Author(s):  
Guifang Zhang ◽  
Xiao Feng ◽  
Kathy Wabner ◽  
Chris Fandrey ◽  
Amir Naqwi ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Pilot Study ◽  
Pars Plana Vitrectomy ◽  
Pars Plana ◽  
Nanoparticle Drug Delivery

Pars plana vitrectomy as anti-inflammatory therapy for intermediate uveitis in children

2010 ◽  
Vol 85 (12) ◽  
pp. 390-394
Author(s):  
M.S. Figueroa ◽  
S. Noval ◽  
I. Contreras ◽  
C. Arruabarrena ◽  
J.L. García-Pérez ◽  
...  
Keyword(s):  
Pars Plana Vitrectomy ◽  
Intermediate Uveitis ◽  
Pars Plana ◽  
Anti Inflammatory

Ocular Perfusion Pressure During Pars Plana Vitrectomy: A Pilot Study

2014 ◽  
Vol 55 (12) ◽  
pp. 8497-8505 ◽  
Author(s):  
T. Rossi ◽  
G. Querzoli ◽  
G. Angelini ◽  
A. Rossi ◽  
C. Malvasi ◽  
...  
Keyword(s):  
Pilot Study ◽  
Pars Plana Vitrectomy ◽  
Perfusion Pressure ◽  
Ocular Perfusion Pressure ◽  
Ocular Perfusion ◽  
Pars Plana

Long-term results of pars plana vitrectomy as an anti-inflammatory therapy of pediatric intermediate uveitis resistant to standard medical treatment

2018 ◽  
Vol 28 (1) ◽  
pp. 98-102 ◽  
Author(s):  
Denisa Darsová ◽  
Pavel Pochop ◽  
Jana Štěpánková ◽  
Dagmar Dotřelová
Keyword(s):  
Visual Acuity ◽  
Pars Plana Vitrectomy ◽  
Immunosuppressive Treatment ◽  
Functional Results ◽  
Long Term Results ◽  
Intermediate Uveitis ◽  
Pars Plana ◽  
Anti Inflammatory ◽  
Standard Medical Treatment

Purpose: To evaluate the efficacy of pars plana vitrectomy (PPV) as an anti-inflammatory therapy in pediatric recurrent intermediate uveitis. Methods: A retrospective study evaluated the long-term results of PPV indicated for intermediate uveitis with a mean observation period of 10.3 years (range 7-15.6 years) in 6 children (mean age 8 years, range 6-12 years). Pars plana vitrectomy was performed on 10 eyes in the standard manner and was initiated by vitreous sampling for laboratory examination. Data recorded were perioperative or postoperative vitrectomy complications, anatomic and functional results of PPV, and preoperative and postoperative best-corrected Snellen visual acuity. Results: No perioperative or postoperative complications were observed. Bacteriologic, virologic, mycotic, and cytologic analysis of the vitreous was negative in all tested children. Five eyes were subsequently operated on for posterior subcapsular cataracts. An average preoperative visual acuity of 0.32 improved to an average postoperative visual acuity of 0.8. Conclusions: In the case of systemic immunosuppressive treatment failure in pediatric uveitis, particularly in eyes with cystoid macular edema, we recommend PPV relatively early.

Sign in / Sign up

Export Citation Format

Share Document